GlassScriptPhysician profile
Timothy Leon Mullins
NPI 1730105404
$1,953.12
in general payments reported to CMS, 2019-2025
13 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $101 · 2021: $95.21 · 2022: $835 · 2023: $220 · 2024: $384 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $855.13 | 2022-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $280.97 | 2022-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Ams 700 |
| Axonics, INC. | $210.34 | 2022 | |
| Janssen Biotech, INC. | $124.99 | 2019 | |
| Myovant Sciences INC. | $95.21 | 2021 | |
| Pfizer INC. | $88.75 | 2019 | |
| Astellas Pharma US INC | $88.32 | 2020 | |
| Urovant Sciences INC | $82.93 | 2022 | |
| Procept Biorobotics Corporation | $33.09 | 2025 | |
| Medtronic, INC. | $32.47 | 2024 | Interstim |
| Photocure INC | $31.20 | 2025 | Cysview |
| Ferring Pharmaceuticals INC. | $17.29 | 2024 | Adstiladrin |
| Kci USA, INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mullins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.